Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

被引：2
|
作者：
Blimark, Cecilie Hveding [1 ,2 ]
Carlson, Kristina [3 ]
Day, Christopher [1 ]
Einarsdottir, Sigrun [1 ]
Juliusson, Gunnar [4 ]
Karma, Moshtak [5 ]
Knut-Bojanowska, Dorota [6 ]
Larfors, Gunnar [7 ]
Turesson, Ingemar [8 ]
Scivetti, Mariana Villegas [1 ]
Sverrisdottir, Ingigerdur [1 ,9 ]
机构：
[1] Sahlgrens Univ Hosp, Dept Haematol & Coagulat, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Med & Clin Nutr, Gothenburg, Sweden
[3] Univ Hosp Uppsala, Uppsala, Sweden
[4] Lund Univ & Hosp, Lund Stem Cell Ctr, Lund, Sweden
[5] Sodra Alvsborg Hosp, Dept Haematol, Boras, Sweden
[6] Uddevalla Cent Hosp, Dept Haematol, Uddevalla, Sweden
[7] Uppsala Univ, Dept Med Sci, Unit Haematol, Uppsala, Sweden
[8] Skane Univ Hosp, Malmo, Sweden
[9] Univ Iceland, Fac Med, Reykjavik, Iceland
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174228
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study
    Usui, Yoshiaki
    Ito, Hidemi
    Koyanagi, Yuriko
    Shibata, Akiko
    Matsuda, Tomohiro
    Katanoda, Kota
    Maeda, Yoshinobu
    Matsuo, Keitaro
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (11) : 3102 - 3109
  • [42] Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
    Redder, Louise
    Klausen, Tobias Wirenfeldt
    Vangsted, Annette Juul
    Gregersen, Henrik
    Andersen, Niels Frost
    Pedersen, Robert Schou
    Plesner, Torben
    Frederiksen, Mikael
    Frolund, Ulf Christian
    Helleberg, Carsten
    Nielsen, Lene Kongsgaard
    Salomo, Morten
    Gimsing, Peter
    Frederiksen, Henrik
    Abildgaard, Niels
    BLOOD, 2019, 134
  • [43] Risk of melanoma in patients with multiple myeloma: A Surveillance, Epidemiology, and End Results population-based study
    Chang, Timothy W.
    Weaver, Amy L.
    Brewer, Jerry D.
    Kyle, Robert A.
    Baum, Christian L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 621 - 623
  • [44] Multiple myeloma in manitoba: A population based study
    Szwajcer, David
    Seftel, Mathew D.
    Dupont, Erin
    Rubinger, Morel
    Schacter, Brent A.
    BLOOD, 2007, 110 (11) : 977A - 977A
  • [45] Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
    Park, Boyoung
    Lee, Eunyoung
    Yoon, Junghyun
    Park, Youngju
    Eom, Hyeon-Seok
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 936 - 944
  • [46] Risk of Early Severe Infections in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Agents: A Pooled Analysis
    Bonello, Francesca
    D'Agostino, Mattia
    Offidani, Massimo
    Petrucci, Maria Teresa
    Liberati, Anna Marina
    Patriarca, Francesca
    Capra, Andrea
    Benevolo, Giulia
    Gaidano, Gianluca
    Barila, Gregorio
    Galli, Monica
    Ponticelli, Elena
    Cascavilla, Nicola
    Angelucci, Emanuele
    Ballanti, Stelvio
    Pietrantuono, Giuseppe
    Pulini, Stefano
    Derudas, Daniele
    de Fabritiis, Paolo
    Corradini, Paolo
    Conticello, Concetta
    Cavo, Michele
    Sonneveld, Pieter
    Boccadoro, Mario
    Bringhen, Sara
    BLOOD, 2020, 136
  • [47] THE SWEDISH MULTIPLE MYELOMA REGISTER: MEDIAN 5-YEAR SURVIVAL OF 7.3 YEARS IN PATIENTS 65 YEARS AND YOUNGER, POPULATION-BASED DATA ON 3,876 MULTIPLE MYELOMA PATIENTS DIAGNOSED 2008-2013
    Blimark, C. H.
    Genell, A.
    Juliusson, G.
    Nahi, H.
    Forsberg, K.
    Turesson, I.
    Ahlberg, L.
    Linder, O.
    Carlsson, K.
    Bjorkstrand, B.
    Kristinsson, S. Y.
    HAEMATOLOGICA, 2016, 101 : 522 - 522
  • [48] The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study
    Thorsteinsdottir, Sigrun
    Sverrisdottir, Ingigerdur S.
    Gislason, Gauti
    Landgren, Ola
    Turesson, Ingemar
    Bjorkholm, Magnus
    Kristinsson, Sigurdur Y.
    BLOOD, 2018, 132
  • [49] Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
    Liu, Yanfang
    Hou, Hsin-An
    Qiu, Hong
    Tang, Chao-Hsiun
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
    Yanfang Liu
    Hsin-An Hou
    Hong Qiu
    Chao-Hsiun Tang
    Scientific Reports, 10
12345